农夫山泉(09633)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09633 农夫山泉

未开盘 09-29 16:08:04

39.520

+0.060

+0.15%

最高39.800	最低38.840	成交量726.81万
今开39.800	昨收39.460	日振幅2.43%
总市值4,444亿	流通市值1,990亿	总股本112.46亿
成交额2.87亿	换手率0.14%	流通股本50.35亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09633","market":"HK","secType":"STK","nameCN":"农夫山泉","latestPrice":39.52,"timestamp":1790669284007,"preClose":39.46,"halted":0,"volume":7268081,"delay":0,"changeRate":0.0015205271160669608,"floatShares":5034666400,"shares":11246000000,"eps":1.6505306602848286,"marketStatus":"未开盘","change":0.06,"latestTime":"09-29 16:08:04","open":39.8,"high":39.8,"low":38.84,"amount":287163838,"amplitude":0.024328,"askPrice":39.52,"askSize":27000,"bidPrice":39.5,"bidSize":160800,"shortable":3,"etf":0,"ttmEps":1.782049060849778,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790731800000},"marketStatusCode":0,"adr":0,"listingDate":1599494400000,"exchange":"SEHK","adjPreClose":39.46,"dividendRate":0.029284,"openAndCloseTimeList":[[1790645400000,1790654400000],[1790658000000,1790668800000]],"volumeRatio":2.0616294973960216,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"NFU.HK","impliedVol":0.2187,"impliedVolPercentile":0.0898},"requestUrl":"/m/hq/s/09633","defaultTab":"news","newsList":[{"id":"1102042164","title":"农夫山泉：钟睒睒增持，好仓比例升至64.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102042164","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102042164?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:32","pubTimestamp":1790674335,"startTime":"0","endTime":"0","summary":"钟睒睒于2026年9月24日在联交所场内以每股均价39.0744港元买入农夫山泉（09633）H股股份35.20万股，涉资约1375.42万港元，属场内主动交易，即在二级市场直接买卖股份。钟睒睒此次增持前持有农夫山泉好仓32.41亿股，占比64.38%；增持后持股量为32.42亿股，好仓比例升至64.39%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290505","title":"港交所数据显示，钟睒睒在农夫山泉的持仓升至64.39%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290505","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671290505?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:26","pubTimestamp":1790674001,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09633","LU1981816686.USD","BK1200","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671138266","title":"万泰生物（603392）9月28日主力资金净买入513.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671138266","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671138266?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:22","pubTimestamp":1790641367,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，万泰生物报收于26.69元，上涨1.18%，换手率0.42%，成交量5.27万手，成交额1.39亿元。近5日资金流向一览见下表：万泰生物融资融券信息显示，融资方面，当日融资买入1115.13万元，融资偿还1074.31万元，融资净买入40.82万元，连续3日净买入累计570.77万元。万泰生物主营业务：体外诊断试剂、体外诊断仪器与疫苗的研发、生产及销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09633","BK1200","BK0239","LU1981816686.USD","BK1589","603392"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171036477","title":"异动解读｜农夫山泉盘中下跌3.02%，报37.94港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171036477","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171036477?lang=zh_cn&edition=full","pubTime":"2026-09-25 10:49","pubTimestamp":1790304587,"startTime":"0","endTime":"0","summary":"9月25日，农夫山泉盘中下跌3.02%，报37.94港元/股，成交额4110.88万港元。农夫山泉所在的软饮料行业中，个股普遍走弱，其中东鹏饮料跌3.1%，中国食品跌2.31%，5100藏冰川跌0.99%，华润饮料跌0.47%，鸿福堂持平。农夫山泉股份有限公司是一家主要从事生产及销售包装饮用水及饮料的中国公司，通过水类产品、即饮茶类产品、功能饮料产品、果汁饮料产品及其他产品五个分部运营，主要在国内市场开展业务。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120495745","title":"农夫山泉2026年中期营收297.18亿元，经调整后净利润88.87亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120495745","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120495745?lang=zh_cn&edition=full","pubTime":"2026-09-24 19:22","pubTimestamp":1790248959,"startTime":"0","endTime":"0","summary":"农夫山泉公布的2026年中期财报显示，期内实现营收297.18亿元人民币，同比增加16.0%。经调整后净利润为88.87亿元人民币，同比上涨16.6%。经营活动所得现金流达107.12亿元人民币，相比去年同期略有提升。包装饮用水产品方面，营收96.41亿元人民币，同比增幅2.1%。果汁饮料产品收入29.22亿元人民币，同比增长14.0%。其他产品营收6.84亿元人民币，同比上升8.7%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"农夫山泉2026年中期营收297.18亿元，经调整后净利润88.87亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09633"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2669464393","title":"万泰生物：二十价肺炎球菌多糖结合疫苗产业化项目相关费用已计入往期财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669464393?lang=zh_cn&edition=full","pubTime":"2026-09-24 18:24","pubTimestamp":1790245450,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物(603392)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：二十价肺炎球菌多糖结合疫苗产业化项目终止后，给合作方的费用以及临床费用是否已经在往期财报中已经体现，后续无需计提？万泰生物回复：您好！公司二十价肺炎球菌多糖结合疫苗产业化项目涉及的合作方款项及临床试验相关费用，均在实际发生时严格按照《企业会计准则》相关规定计入对应会计期间的当期费用，已完整体现在公司往期各期财报中，后续无需就该项目相关合作款项及临床试验费用进行额外计提。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400032238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603392","159646","09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464392","title":"万泰生物：公司仪器确认销售收入的时点为客户验收，已发货未验收的仪器计入发出商品","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464392","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669464392?lang=zh_cn&edition=full","pubTime":"2026-09-24 18:24","pubTimestamp":1790245449,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物(603392)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问从2024年底开始，财报中存货分类部分，多了一个“发出商品”的分类统计项目，请问该项目是用来做什么的？目前该项目中主要是那类商品？万泰生物回复：您好！公司仪器确认销售收入的时点为客户验收，已发货未验收的仪器计入发出商品。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400032231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603392","BK1589","LU1981816686.USD","BK1200","BK0239","09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669046108","title":"万泰生物：公司经营一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2669046108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669046108?lang=zh_cn&edition=full","pubTime":"2026-09-24 18:21","pubTimestamp":1790245265,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物(603392)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问万泰是不是废了？二级市场的股价怎么跌跌不休？万泰生物回复：您好！理解您对股价持续下跌的焦虑，二级市场股价变动受诸多因素影响。目前公司经营一切正常，疫苗、诊断等业务稳步推进，各项研发与市场拓展工作有序开展。管理层将持续深耕主业、提质增效，夯实长期价值。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400032147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09633","603392","BK0239","BK1589","LU1981816686.USD","BK1200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646140","title":"万泰生物：二价HPV疫苗已在泰国、印度尼西亚、柬埔寨、缅甸等国家获得市场准入","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646140","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669646140?lang=zh_cn&edition=full","pubTime":"2026-09-24 18:18","pubTimestamp":1790245094,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物(603392)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好：请问贵司的HPV疫苗在东盟国家内的准入情况如何。 东盟总人口超过6亿，且具备良好的购买能力，HPV疫苗出口该地区可以实现社会效益和商业效益。万泰生物回复：您好！公司高度重视东盟国家市场的布局与拓展。目前，二价HPV疫苗已在泰国、印度尼西亚、柬埔寨、缅甸等国家获得市场准入；九价HPV疫苗已获得泰国上市许可。在技术合作方面，公司已与泰国合作伙伴完成九价HPV疫苗技术转移。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400032083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09633","159646","LU1981816686.USD","603392","BK0239","BK1200","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669548109","title":"万泰生物（603392）披露关于终止部分募投项目并变更募集资金用途的议案，9月23日股价上涨2.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669548109","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669548109?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:14","pubTimestamp":1790172854,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，万泰生物报收于26.93元，较前一交易日上涨2.71%，最新总市值为340.5亿元。该股当日开盘26.19元，最高27.3元，最低26.06元，成交额达2.3亿元，换手率为0.68%。公告显示，公司于2026年9月23日召开2026年第一次临时股东会，审议通过《关于终止部分募投项目并变更募集资金用途的议案》，表决结果为同意948,485,661股，占出席会议有表决权股份的99.9497%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300040745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09633","LU1981816686.USD","BK0239","BK1200","603392","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669481772","title":"万泰生物：2026年第一次临时股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2669481772","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669481772?lang=zh_cn&edition=full","pubTime":"2026-09-23 20:38","pubTimestamp":1790167080,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月23日，万泰生物发布公告称，公司于2026年9月23日召开2026年第一次临时股东会，审议通过《关于终止部分募投项目并变更募集资金用途的议案》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-23/doc-inisvqcx5322244.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-23/doc-inisvqcx5322244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1981816686.USD","603392","BK1200","09633","BK1589","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182522092","title":"农夫山泉：钟睒睒增持，好仓比例升至64.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182522092","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182522092?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:43","pubTimestamp":1790156598,"startTime":"0","endTime":"0","summary":"钟睒睒通过其100%控股的养生堂有限公司于2026年9月18日在联交所场内以每股均价38.6839港元买入农夫山泉股份有限公司H股股份49.90万股，涉资约1930.33万港元，属场内主动交易，即在二级市场直接买卖股份。钟睒睒此次增持前持有农夫山泉好仓32.40亿股，占比64.36%；增持后持股量为32.41亿股，好仓比例升至64.37%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107172555","title":"农夫山泉：钟睒睒增持，好仓比例升至64.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107172555","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107172555?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:41","pubTimestamp":1790156505,"startTime":"0","endTime":"0","summary":"钟睒睒通过其全资控股的养生堂有限公司于2026年9月17日在联交所场内以每股均价38.8334港元买入农夫山泉H股股份49万股，涉资约1902.84万港元，属场内主动交易，即在二级市场直接买卖股份。钟睒睒此次增持前持有农夫山泉好仓32.40亿股，占比64.35%；增持后持股量为32.40亿股，好仓比例升至64.36%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669587102","title":"农夫山泉在宁波成立食品公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2669587102","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669587102?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:40","pubTimestamp":1790156400,"startTime":"0","endTime":"0","summary":"人民财讯9月23日电，企查查APP显示，近日，农夫山泉(宁波)食品有限公司成立，法定代表人为向咸松，注册资本为1000万元，经营范围包含：食品销售(仅销售预包装食品)；包装材料及制品销售；日 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260923/c680221213.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260923/c680221213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["09633","159151","LU1981816686.USD","BK1200","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668310966","title":"万泰生物：公司高价肺炎球菌多糖结合疫苗按计划推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2668310966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668310966?lang=zh_cn&edition=full","pubTime":"2026-09-17 18:15","pubTimestamp":1789640127,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物(603392)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问：后续要推进的：高价肺炎球菌多糖结合疫苗项目，目前是否有后选疫苗存在？万泰生物回复：您好！公司高价肺炎球菌多糖结合疫苗按计划推进中。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700030532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK1200","09633","LU1981816686.USD","603392","BK1589","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668966326","title":"万泰生物：公司始终恪守诚信经营原则","url":"https://stock-news.laohu8.com/highlight/detail?id=2668966326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668966326?lang=zh_cn&edition=full","pubTime":"2026-09-17 18:15","pubTimestamp":1789640126,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物(603392)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，你们的董事长邱先生，不是热衷于做慈善工作吗？那么，一个心怀慈悲的人，就更应该带动团队诚实守信的公布九价疫苗的销售进度与收入情况。万泰生物回复：您好！公司董事长及管理层高度重视社会责任与公益事业，践行企业担当；同时公司始终恪守诚信经营原则，严格按照证券法及上交所信息披露规则履行信息披露义务，保障全体投资者公平获取公司经营信息。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700030530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","BK1200","09633","603392","BK0239","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668396637","title":"万泰生物：在信息披露中需遵守监管要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2668396637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668396637?lang=zh_cn&edition=full","pubTime":"2026-09-17 18:15","pubTimestamp":1789640125,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物09月17日在投资者关系平台上答复投资者关心的问题。请转告邱董及管理层。还不如前董秘余涛回复的一个批次15万到30万的实在，坦率，有价值。感谢您参加本次业绩说明会并直言反馈。在信息披露中，公司需要遵守监管要求，兼顾全体投资者信息公平与商业秘密保护，部分细分数据存在披露限制。公司将在合规前提下持续优化业绩沟通方式，提升沟通实效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700030528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","603392","BK1200","09633","LU1981816686.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668663219","title":"万泰生物：公司聚焦于体外诊断试剂和预防产品的业务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2668663219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668663219?lang=zh_cn&edition=full","pubTime":"2026-09-17 18:15","pubTimestamp":1789640124,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物09月17日在投资者关系平台上答复投资者关心的问题。另外关于养生堂的治疗性板块纳入万泰生物的紧迫性公司高层是否考虑过？公司与养生堂对生物医药领域的业务范围进行了界定划分：公司从事以疾病诊断、疾病预防为目的的产品的研发及产业化，养生堂从事以疾病治疗为目的的产品的研发及产业化。万泰生物聚焦于体外诊断试剂和预防产品的业务领域，治疗性创新药物属于养生堂集团的业务范围。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700030525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09633","BK1200","BK0239","603392","BK1589","LU1981816686.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668457965","title":"万泰生物：九价 HPV 疫苗与二价 HPV 疫苗的市场环境、商业化基础不同","url":"https://stock-news.laohu8.com/highlight/detail?id=2668457965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668457965?lang=zh_cn&edition=full","pubTime":"2026-09-17 18:06","pubTimestamp":1789639573,"startTime":"0","endTime":"0","summary":"九价 HPV 疫苗与二价 HPV 疫苗的市场环境、商业化基础不同，不宜直接对比。九价 HPV 疫苗上市后，各省准入、渠道建设、市场教育均需要一定周期，新品上市阶段在准入、推广、团队建设方面投入较高，存在阶段性经营压力，是创新疫苗商业化过程中的常见情况。不同疫苗的目标市场、竞争格局存在差异，成长周期各不相同。公司后续会持续拓展海内外市场、优化渠道运营，稳步提升九价HPV疫苗市场销量与品牌影响力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700030343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1981816686.USD","603392","09633","BK1589","BK1200","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667963190","title":"农夫山泉起诉“国赤山泉”侵权索赔15万，创始人：还未投放市场，样品早已下架","url":"https://stock-news.laohu8.com/highlight/detail?id=2667963190","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667963190?lang=zh_cn&edition=full","pubTime":"2026-09-14 10:09","pubTimestamp":1789351740,"startTime":"0","endTime":"0","summary":"9月14日，近日“国赤山泉”创始人发文称，已收到来自农夫山泉股份有限公司的起诉。据其晒出的民事起诉状显示，农夫山泉以“侵害商标权纠纷”为由向“国赤山泉”索赔经济损失、合理费用共计15万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/shenji/2026-09-14/doc-iniruare7345575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09633","BK1200","BK1589","LU1981816686.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nongfuspring.com","stockEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":-0.0915},{"period":"3month","weight":-0.0025},{"period":"6month","weight":-0.1468},{"period":"1year","weight":-0.2429},{"period":"ytd","weight":-0.1337}],"compareEarnings":[{"period":"1week","weight":-0.0225},{"period":"1month","weight":-0.0415},{"period":"3month","weight":0.0718},{"period":"6month","weight":-0.0236},{"period":"1year","weight":-0.0789},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"农夫山泉股份有限公司是一家主要从事生产及销售包装饮用水及饮料的中国公司。该公司通过五个分部运营。水类产品分部从事制造及销售天然包装饮用水。即饮茶类产品分部从事制造及销售即饮茶。功能饮料产品分部从事制造及销售功能饮料。果汁饮料产品分部从事制造及销售果汁饮料产品。其他产品分部从事制造及销售农产品及其他饮料。该公司主要在国内市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.003567},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.016331},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.07575},{"month":4,"riseRate":0.666667,"avgChangeRate":0.026458},{"month":5,"riseRate":0.666667,"avgChangeRate":0.019912},{"month":6,"riseRate":0.5,"avgChangeRate":-0.035833},{"month":7,"riseRate":0.833333,"avgChangeRate":0.029658},{"month":8,"riseRate":0.333333,"avgChangeRate":0.002159},{"month":9,"riseRate":0.5,"avgChangeRate":0.026439},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.055387},{"month":11,"riseRate":0.833333,"avgChangeRate":0.094346},{"month":12,"riseRate":0.666667,"avgChangeRate":0.06968}],"exchange":"SEHK","name":"农夫山泉","nameEN":"NONGFU SPRING"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"农夫山泉(09633)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供农夫山泉(09633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"农夫山泉,09633,农夫山泉股票,农夫山泉股票老虎,农夫山泉股票老虎国际,农夫山泉行情,农夫山泉股票行情,农夫山泉股价,农夫山泉股市,农夫山泉股票价格,农夫山泉股票交易,农夫山泉股票购买,农夫山泉股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"农夫山泉(09633)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供农夫山泉(09633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}